AI Security and Compliance in Pharmaceuticals
Trustwise delivers an AI Security and Control Layer, including AI Trust Management for Agentic AI Systems. Modern AI projects often face challenges in scaling not due to a lack of ambition, but because of unreliability, inefficiency, and lack of control. This creates the Trust Gap, which is a critical barrier to achieving widespread AI adoption. The emergence of agentic AI only widens this gap, introducing greater complexity and risk. Our solutions, Harmony Ai, are designed to minimize the Trust Gap throughout the entire AI lifecycle, from simulation and verification to optimization and governance. Trustwise helps large organizations realize AI Trust and Security at scale.
Exfiltration: Understanding the Threat
The Significance of Exfiltration
Exfiltration, the unauthorized transfer of data from a computer or network, presents a significant threat to organizations, particularly in the pharmaceutical industry. With sensitive intellectual property, research data, and patient information at stake, knowing and mitigating the risks associated with exfiltration is crucial for maintaining data integrity and confidentiality.
Common Methods of Exfiltration
Exfiltration can occur through various methods, including but not limited to:
– Data Over the Network: Attackers can transfer data through network connections, exploiting vulnerabilities in the organization’s infrastructure or using unauthorized access.
– Removable Media: Malicious actors may use external storage devices, such as USB drives, to physically remove sensitive data from the premises.
– Cloud Services: Unauthorized access to cloud storage or file-sharing services can facilitate the unauthorized transfer of data outside the organization’s control.
Implications of Exfiltration
Exfiltration poses serious implications for pharmaceutical companies, including:
– Intellectual Property Theft: Loss of proprietary research and development data can compromise the organization’s competitive advantage and future innovations.
– Regulatory Non-Compliance: Breaches involving patient data can lead to severe regulatory repercussions, damaging the company’s reputation and financial stability.
– Financial Loss: Data exfiltration can result in significant financial losses, including legal fees, remediation costs, and potential revenue decline.
Mitigating Exfiltration Risks with Trustwise
Trustwise’s advanced AI Security and Control Layer offers comprehensive solutions to mitigate the risks of exfiltration, providing the Chief Technical Officer with the necessary tools to safeguard the organization’s sensitive data and intellectual property.
– Real-time Security and Control: Trustwise embeds real-time security, control, and alignment into every agent, ensuring that innovation scales without compromising control.
– Shielded Agents: We transform naked agents into Shielded Agents, protecting them from potential exfiltration attempts and unauthorized data transfers.
– Trust-as-Code: Our solutions deliver trust-as-code through APIs, SDKs, MCPs, and Guardian Agents, offering flexible implementation based on the organization’s specific needs.
Schedule Demo
To experience the full potential of Trustwise’s AI Security and Control Layer and understand how our solutions can effectively mitigate exfiltration risks in your pharmaceutical organization, schedule a demo with us today.
